Fraser Wright, PhD, will join Axovant (AXON) as Chief Technology Officer overseeing the company’s gene therapy initiatives. Dr. Wright is the Co-Founder and former Chief Technology Officer of Spark Therapeutics (ONCE) and has over 20 years of leadership experience in the development of novel vector-based biologic products.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.